Company intelligence / Profile preview

Scent Medical Technologies

Tel Aviv-Jaffa, Central District, Israelprnewswire.com ↗

Ownership: Private
Development stage: Other

Overview

Scent Medical Technologies develops noninvasive real-time screening solutions for infectious diseases using a simple breath test. Their platform provides instant results and was used in a clinical trial to monitor antibody levels post-COVID vaccination. The company was involved in a merger with Nextgen Biomed Ltd., with the merged entity to be called Scentech Medical. No published late-stage pivotal data found.

Therapeutic areas: Infectious DiseasesOther
Modalities: DeviceNon-pharmacological therapy
Industry: Metabolite Diagnostics

Partnerships

Nextgen Biomed Ltd.

Beyond the preview

Go deeper on Scent Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scent Medical Technologies.

Explore the full profile